Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.0117 | 0.2842 | 0.5 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0117 | 0.2842 | 0.2842 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0 | 0.5 |
Trypanosoma brucei | RNA helicase, putative | 0.0214 | 1 | 0.5 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0117 | 0.2842 | 0.2842 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0117 | 0.2842 | 0.2842 |
Brugia malayi | Melibiase family protein | 0.0078 | 0 | 0.5 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0117 | 0.2842 | 0.2842 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.0078 | 0 | 0.5 |
Toxoplasma gondii | melibiase subfamily protein | 0.0117 | 0.2842 | 0.5 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.0117 | 0.2842 | 0.5 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.0117 | 0.2842 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 21.3 uM | Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells | ChEMBL. | 19362847 |
IC50 (binding) | = 24.7 uM | Inhibition of recombinant IGFR1 | ChEMBL. | 19362847 |
IC50 (binding) | = 26.1 uM | Inhibition of recombinant MET | ChEMBL. | 19362847 |
IC50 (binding) | = 30.5 uM | Inhibition of human recombinant IRK | ChEMBL. | 19362847 |
IC50 (binding) | = 33.5 uM | Inhibition of recombinant JAK2 | ChEMBL. | 19362847 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.